News on CRISPR, gene editing, RNAi in genetics, genomics, and molecular diagnostics.
DuPont Pioneer has acquired the exclusive rights to ERS Genomics' portfolio of CRISPR-Cas genome-editing technologies for all plant and agricultural applications.
The deal allows St. Louis-based Canopy to access Cosmo's Japanese academic and pharma customers for its gene editing and personalized medicine technologies.
The company said its proxy-CRISPR tool can facilitate precise gene editing and eliminates the need for genetic engineering of naturally occurring CRISPR proteins.
Taconic Biosciences said that it will use ERS Genomics' CRISPR-Cas9 technology to generate unique murine models.
Designing successful gene drives using CRISPR will require that researchers characterize the genetic variability and mating systems of target populations.
Two new Reproducibility Project: Cancer Biology studies have largely reproduced the original findings, ScienceInsider reports.
DNA fingerprinting could catch some sample mix-ups at pathology labs, the New York Times says.
A Maryland police department has turned to DNA phenotyping to develop a suspect sketch, WJLA reports.
In Cell this week: DNA methylation and T cell exhaustion, longevity in C. elegans, and more.